A Director of Midven since 2004 and Fund Principal of the UK Innovation and Science Seed Fund.

After an initial scientific career at Zeneca, Andrew went on to roles in research and business development at the medical device company Biocompatibles and then Vice President of Technology for a US start-up in disinfection of medical equipment.

He started his career in VC with the £4m per annum Invention and Innovation seed capital fund at NESTA (the National Endowment for Science Technology and the Arts). He has a degree and a PhD in Chemistry from the University of Oxford.